Background. The majority of thyroid cancer diagnoses in the United States are stage I well-differentiated cancer. The use of radioactive iodine (RAI) in these low-risk patients has increased over time. The role of surgeon training in decision making regarding treatment with RAI is unknown. Methods. Thyroid surgeons affiliated with 368 hospitals associated with the US National Cancer Database (NCDB) were surveyed. Survey data were linked to the NCDB data. A multivariable weighted analysis controlling for surgeon and hospital characteristics was conducted to examine the relationship between surgeon training, continuing education and hospital-level RAI use for stage I welldifferentiated thyroid cancer. Results. The response rate was 70 % (560 of 804). In both univariate and multivariable analysis controlling for hospital case volume, practice setting and surgeon specialty, training with a thyroid surgeon was associated with less RAI use for stage I thyroid cancer (P = 0.022 and 0.028, respectively). Attending one or more professional society meetings a year was associated with a lower rate of hospital-level RAI use in univariate analysis (P = 0.044) but not multivariable analysis. Conclusions. Training with a surgeon or group of surgeons who focus on thyroid surgery was associated with a lower proportion of stage I thyroid cancer patients receiving RAI after total thyroidectomy. This study emphasizes the importance of surgeon training in hospital practice patterns.
The increased incidence of thyroid cancer in the United States has been well-documented. 1, 2 According to the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER), thyroid cancer diagnoses have increased at a rate of 6.6 % a year from 1997 to 2009 and the majority of these new cases are low-risk stage I welldifferentiated thyroid cancer. 1, 3 Treatment for thyroid cancer typically consists of surgery, often followed by radioactive iodine (RAI). Recent clinical guidelines have recommended against RAI use in very low-risk patients (intrathyroidal cancer B 1 cm) but still leave RAI use up to the provider for the majority of low-risk patients. 4 Because most peer-reviewed studies have found no statistically significant improvement in mortality or disease-specific survival in low-risk patients treated with RAI, 5 factors that affect RAI use require more study.
Although the rise in RAI use for thyroid cancer over time is well documented, it is not known if surgeon training and continuing education influence its use. 6, 7 Our previous study shows that 74 % of surveyed surgeons are involved in RAI decision making and when the surgeon or endocrinologist is the primary decision maker there is less RAI use for low-risk patients than when the primary decision maker is in another specialty. 8 Prior studies suggest that surgeon training affects surgical outcomes and management. 9, 10 In addition, surgeon training has been shown to affect extent and choice of treatment. 11 We hypothesized that the knowledge and confidence obtained during surgeon training would also influence the subsequent downstream medical management of thyroid cancer patients.
To assess the relationship between surgeon training/ continuing education and hospital-level RAI use for lowrisk thyroid cancer, we linked surgeon survey data to data on hospital RAI use for stage I well-differentiated thyroid cancer from the National Cancer Database (NCDB).
METHODS

Data Source and Study Population
Between 2004 and 2008, there were 1,282 Commission on Cancer-accredited hospitals that treated thyroid cancer patients. Of these, we selected the 1,159 hospitals that reported to the American College of Surgeons' Commission on Cancer four of the five specified years. We eliminated the 235 hospitals that treated 6 or less cancer patients a year. We then randomly sampled 589 hospitals across quartiles of case volume and RAI use.
We contacted the hospital registrar at the 589 hospitals as well as searched hospital websites to identify the surgeons who performed the majority of the thyroid cancer operations at each hospital. We identified 850 surgeons affiliated with the 589 hospitals.
Before administering the survey, the instrument was designed and piloted in a multidisciplinary group of providers. The instrument contained both survey questions and clinical vignettes. The survey was then administered between February and June 2011. The Dillman survey method was used to encourage survey response. 12 This three wave method consists of the following: (1) an initial mailing of an introductory letter, the survey instrument, a postage-paid return envelope, and a gift; (2) a postcard reminder; (3) a second identical survey with a postage-paid return envelope to all nonresponders.
Data from the returned surveys were scanned and verified. The surgeon survey responses were then linked to the NCDB, a joint project of the American College of Surgeons and the American Cancer Society.
All surgeon data were deidentified and reported in summary form only. Exemption was granted for this study by the University of Michigan Institutional Review Board.
Measures
Responses regarding residency program type, whether or not there was ''a surgeon or group of surgeons who focused on thyroid surgery'' in his or her training program, professional society membership, attendance at national meetings, practice setting, surgeon specialty, and awareness of the 2006 American Thyroid Association (ATA) and/or 2007 National Comprehensive Cancer Network (NCCN) clinical guidelines were obtained from the survey data. The dependent variable (the hospitals' proportion of stage I well-differentiated thyroid cancer patients treated with RAI after total thyroidectomy between 2004 and 2008) and one independent variable (hospital thyroid cancer case volume) were obtained from the NCDB.
Hospital case volume was categorized into quintiles as described by Haymart et al. 6 The lower quintile was excluded as described above. The remaining four case volume categories were the following: Low (7-11 cases/ year), Low-Medium (12-19 cases/year), Medium (20-34 cases/year), and High (C 35 cases/year). For the question pertaining to practice setting because surgeons could select more than one choice, an algorithm described by Alderman et al. was used. 13 If academic tertiary care center was selected (including when community based academic affiliate and private practice were also selected) then the practice setting was classified as academic. When community based academic affiliate was selected (including when private practice was selected) then the practice setting was classified community. If only private practice was selected, then the practice setting was classified as private practice. A similar algorithm was employed for the question regarding type of residency program. Respondents who selected multidisciplinary cancer center and another residency program were classified as multidisciplinary cancer center. Those who selected academic medical center and community hospital were classified as academic medical center. If only community hospital was selected, then the residency program was classified as community.
Statistical Analysis
When more than one surgeon responded from the same hospital, the surveys were weighted by reported surgeon case volume. Surgeon case volume was categorized as 1, 5, 25, 50, or 100 based on the lower limit of the selected thyroid cancer case volume range per year (from the 0-4 interval, the assigned value was 1).
Univariate analysis was used to compare training and continuing education with RAI use for stage I thyroid cancer. The surgeons were compared across specialization, training, professional membership, national meeting attendance, and clinical guidelines awareness. In addition, we looked at associations between surgeon specialty and training with a thyroid surgeon.
Multivariable weighted regression controlling for hospital case volume, practice setting, and surgeon specialty was used to analyze the relationship between training with a thyroid surgeon and RAI use. We repeated the multivariable analysis with only those surgeons who reported being involved in RAI decision making (413 of 560, 74 %) and the findings did not change. Finally, we evaluated statistical interaction between training with a thyroid surgeon and reading the clinical guidelines.
All statistical tests were performed by SAS 9.2 (SAS Institute, Cary, NC). Two-sided tests were used with P \ 0.05 considered statistically significant.
RESULTS
Forty-six of the 850 surgeons were found to be ineligible because deceased, ill, retired, no longer treating thyroid cancer patients, or incorrect mailing address. Of the 804 response eligible surgeons, 560 (70 %) completed the survey. The 560 surgeons represent 368 of the sampled hospitals (62 %). Table 1 shows the respondent characteristics. Of the 560 survey respondents, 90 % were men and 10 % women. The mean surgeon age was 51 years, and the surgeons averaged 19 years in practice. For practice setting, 23 % currently practice at academic medical centers, 16 % at a community-based academic affiliate, and 61 % are in private practice. General surgeons comprised 39 % of the respondents, 9 % were classified as endocrine surgeons, 44 % otolaryngologists, and 8 % in another surgical specialty.
Respondent Characteristics
Univariate Analysis
Univariate analysis of training/continuing education and RAI use between 2004 and 2008 for stage I thyroid cancer is displayed in Table 2 . A majority of respondents attended one or more professional society meetings per year (63 %). Our analysis showed that physicians attending one or more professional society meetings per year were significantly less likely to utilize postoperative RAI for stage I thyroid cancer (P = 0.044). Three-quarters of surgeons reported having a surgeon or group of surgeons who focused on thyroid surgery in their training program. There was a statistically significant inverse relationship between training with a surgeon or group of surgeons who focused on thyroid surgery and hospital-level RAI use (P = 0.022). There was no statistical interaction between training with a thyroid surgeon and attending one or more national meetings per year.
The majority of surgeons completed their residency at an academic medical center (79 %), with the remainder doing so at a community hospital (12 %) or multidisciplinary cancer center ( 
Multivariable Analysis
Multivariable weighted analysis (Table 3) confirmed the significantly lower hospital-level RAI use when the affiliated surgeon trained with a surgeon or group of surgeons who focused on thyroid surgery (P = 0.028). As previously documented, 14 hospital case volume and general surgeon specialty were independently associated with a greater hospital-level use of RAI for stage I disease. In this multivariable analysis practice setting and attending one or more national meeting a year were not associated with a statistically significant difference in RAI use.
Subgroup Analysis
We found an association between surgeon specialty and likelihood of training with a surgeon or group of surgeons who focused on thyroid surgery (P = 0.042). While 88 % of endocrine surgeons trained with a surgeon or group of surgeons with thyroid cancer expertise, 72 and 74 % of otolaryngologists and general surgeons, respectively, trained with a thyroid surgeon (Fig. 1) . Data are presented as n (%) or mean ± SD Surgeon Training and Radioactive Iodine
DISCUSSION
The results of this study improve our understanding of the relationship between surgeon training/continuing education and hospital RAI use. In univariate analysis, attending one or more professional society meetings per year was associated with less hospital-level RAI use for stage I thyroid cancer. In both univariate and multivariable analysis, training with a surgeon or group of surgeons who focused on thyroid surgery was associated with lower hospital rates of RAI use for stage I thyroid cancer. Otolaryngologists and endocrine surgeons were least and most likely, respectively, to have a surgeon or group of surgeons who focused on thyroid surgery at their training program.
As described in Haymart et al. 6 between 1990 and 2008, patients diagnosed with low-risk thyroid cancer were being treated with RAI at an increasing rate after total thyroidectomy. There was wide variation in RAI use with a large proportion of it being attributed to unexplained hospital characteristics. 6 Within the hospital are physician decision makers. As one of the primary decision makers in the care of thyroid cancer patients, the surgeon's attitudes toward treatment decisions are very important. This current study sheds light on how those attitudes are formed. Previous studies have evaluated the relationship between surgeon specialization or thyroid surgical volume and surgical outcomes. 9, 10, 15 In addition, studies have evaluated the role of surgical training on surgeon competence and confidence. [16] [17] [18] Our study is novel because it evaluates surgical training and subsequent medical management. This study suggests that surgeon training either directly influences surgeon decision-making on medical management after surgery or alternatively is associated with hospital-wide practice patterns.
One plausible explanation for our findings in this study is that training informs the manner in which a surgeon is likely to continue to practice. Recent data from general surgery show that surgeons in residency training have variable, and often limited, exposure to some procedures that program directors believe they should be competent to perform independently at the completion of residency. 19 This variation in experience provided by training programs may explain why some surgery residents worry that they will not feel confident performing procedures independently and believe that they must complete further specialty training to be fully competent. 16 The presence of an endocrine surgery program in a specific general surgery training program can enhance the technical skill and experience of the finishing residents. 17 Although the increased number of endocrine procedures performed in the United States has resulted in both general surgery and otolaryngology residents gaining more experience during residency, otolaryngology residents participate in nearly twice as many thyroid and parathyroid procedures as general surgery residents. 20 However, there is substantial variability among training programs in both general surgery and otolaryngology, as the maximum number of thyroid cases performed during residency is more than five times the mean. 20 Thus, it seems possible that training with a thyroid surgeon provides increased focused experience that instills greater confidence in surgical skills and a more sophisticated view of thyroid disease management. This could allow a surgeon to feel less dependent on RAI, and to have a more nuanced understanding of the indications for RAI. In addition, it is also possible that the confidence of other colleagues in the adequacy of surgical resection influences hospital RAI use such that a well-trained surgeon and colleagues involved in decision making are less reliant on RAI.
The strengths of this study include a large sample size, a diverse group of surgeon specialties, a high response rate among surgeons, a novel research design, and data on hospital-level RAI use. There are also limitations. First, nonresponse bias is a known limitation of survey studies. Next, while survey questions are a common method of assessing provider practice patterns, we cannot be sure that provider report alone is adequate. 13, 21, 22 Third, we cannot verify that the respondents treated all patients at the affiliated hospital. To remediate this potential limitation, we requested the hospital registrars provide us with the names of the highest volume thyroid surgeons and as previously described in Methods, and if more than one surgeon was surveyed from the same hospital, we then weighted the answers according to surgeon reported case volume.
In conclusion, as the use of RAI in stage I well-differentiated thyroid cancer patients increases and its appropriateness is debated, it is important to identify the characteristics of the decision-makers that are associated with a lesser or greater likelihood of treating with RAI after thyroidectomy. [5] [6] [7] 23, 24 This study finds a significant association between training with a thyroid surgeon during residency or fellowship and lower hospital-level use of RAI for stage I thyroid cancer. The results suggest that practice patterns are formed early because training with a thyroid surgeon had more influence on treatment patterns than meeting attendance, professional society membership, and clinical guideline awareness. These findings have implications for both future intervention studies and for surgeon training. These results suggest that to initiate change in hospital practice patterns with potential for improved adherence to clinical guidelines; we need to focus on physician training.
